Profile data is unavailable for this security.
About the company
Cilo Cybin Holdings Limited is a South Africa-based biotech investment company. The Company's main operations are identifying viable investments in biotech, biohacking and pharmaceutical businesses. It is focused on supplying Good Manufacturing Practices (GMP) medical cannabis products, including GMP Cannabidiol (CBD), CBG, CBN isolates and GMP delta-9-tetrahydrocannabinol (THC), and CBD distillates. Its products include bulk products, THC distillate, CBD isolate, house brand and finished products. It specializes in supplying medical-grade cannabis flower and final products, using a cold ethanol extraction process with input materials. It caters to both bulk packaging and customized specifications, suitable for various applications, including vape products, oils, and edible formulations. It also offers cannabis active pharmaceutical ingredients (API) products. Its products can be used in various applications, such as vape products, tinctures, edibles, and topicals.
- Revenue in ZAR (TTM)--
- Net income in ZAR--
- Incorporated2022
- Employees--
- LocationCilo Cybin Holdings Ltd7 Sterling StreetThe Point Office Park Unit C1CENTURION South AfricaZAF
- Websitehttps://cilocybin.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Althea Group Holdings Ltd | 358.03m | -377.88m | 205.45m | -- | -- | 55.67 | -- | 0.5738 | -0.0858 | -0.0858 | 0.0808 | 0.0008 | 0.8438 | 2.34 | 7.03 | -- | -89.06 | -37.78 | -167.97 | -47.13 | 60.70 | 53.83 | -105.54 | -94.47 | 0.4086 | -4.08 | 0.9466 | -- | 20.87 | 99.01 | -133.57 | -- | -25.27 | -- |
| Talphera Inc | 7.27m | -250.32m | 205.51m | 15.00 | -- | 0.8838 | -- | 28.27 | -0.6353 | -0.6323 | 0.0185 | 0.7491 | 0.0187 | -- | -- | 26,533.33 | -64.37 | -22.60 | -78.11 | -28.55 | -- | -- | -3,443.22 | -714.87 | -- | -- | 0.00 | -- | -- | -21.26 | -119.16 | -- | -34.33 | -- |
| Calmer Co International Ltd | 50.25m | -43.93m | 207.60m | -- | -- | -- | -- | 4.13 | -0.0035 | -0.0035 | 0.0038 | -0.0003 | 1.13 | 2.01 | 9.14 | -- | -98.45 | -119.20 | -395.42 | -195.49 | 49.62 | 39.01 | -87.42 | -219.69 | 0.5607 | -12.30 | 1.27 | -- | 138.92 | 87.79 | 28.91 | -- | -20.42 | -- |
| JFL Life Sciences Ltd | -21.63bn | -21.63bn | 208.35m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 8.63 | -- | 50.42 | -- | -- | -- |
| Cilo Cybin Holdings Ltd | -100.00bn | -100.00bn | 213.05m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 182.51 | -- | -- | -- |
| Kane Biotech Inc | 9.84m | -71.15m | 214.12m | -- | -- | -- | -- | 21.77 | -0.042 | 0.0374 | 0.0059 | -0.0055 | 0.1568 | 0.3751 | 3.23 | -- | -113.43 | -77.89 | -- | -- | 60.54 | 43.27 | -723.31 | -241.85 | 0.5679 | -4.73 | 1.43 | -- | -94.42 | -20.26 | -17.29 | -- | -19.41 | -- |
| Bio Essence Corp | 10.84m | -18.72m | 215.99m | 12.00 | -- | -- | -- | 19.93 | -0.0278 | -0.0156 | 0.0158 | -0.0458 | 0.3305 | -- | 21.20 | -- | -57.09 | -46.10 | -- | -- | 25.05 | 33.89 | -172.74 | -111.21 | -- | -59.99 | 7.03 | -- | -11.27 | -10.94 | -52.03 | -- | -48.19 | -- |
| Biofil Chemicals and Pharmaceuticals Ltd | 99.57m | 1.37m | 220.20m | -- | 157.29 | -- | 99.35 | 2.21 | 0.3978 | 0.3978 | 28.96 | -- | -- | -- | -- | -- | -- | 2.74 | -- | 5.36 | 4.94 | 9.99 | 1.38 | 2.80 | -- | 7.63 | -- | -- | 33.29 | 11.60 | 26.55 | 8.02 | -56.15 | -- |
| Sanai Health Industry Group Co Ltd | 246.58m | 33.02m | 222.52m | 156.00 | 7.13 | 0.2704 | 9.20 | 0.9024 | 0.087 | 0.087 | 0.7229 | 2.29 | 0.2261 | 13.97 | 6.37 | 1,544,793.00 | 1.74 | 2.31 | 2.21 | 3.65 | 17.99 | 34.87 | 7.71 | 6.56 | 4.10 | -3.68 | 0.1077 | 0.00 | -30.60 | 16.04 | -36.23 | -- | -75.21 | -- |
| Pila Pharma AB | 1.72m | -11.49m | 222.96m | 0.00 | -- | 45.74 | -- | 129.86 | -0.3165 | -0.3165 | 0.049 | 0.1082 | 0.2602 | -- | 8.21 | 1,034,020.00 | -174.06 | -108.88 | -276.40 | -121.45 | -406.94 | -42.67 | -668.94 | -1,577.64 | -- | -163.35 | 0.00 | -- | -22.21 | -- | 62.92 | -- | -- | -- |
| Millennium Pharmacon Internationl Tbk PT | 4.43bn | 30.95m | 231.90m | 1.17k | 7.49 | 0.6822 | 4.10 | 0.0523 | 21.09 | 21.09 | 3,020.28 | 231.59 | 2.31 | 6.56 | 4.96 | 3,334,348,000.00 | 1.61 | 1.21 | 7.76 | 5.62 | 8.54 | 8.40 | 0.6975 | 0.5213 | 0.7349 | 1.61 | 0.7356 | 11.46 | 5.08 | 7.20 | 35.25 | 11.22 | 27.63 | -3.58 |
